Literature DB >> 17314973

Pathogenesis and therapy of psoriasis.

Michelle A Lowes1, Anne M Bowcock, James G Krueger.   

Abstract

Psoriasis is one of the most common human skin diseases and is considered to have key genetic underpinnings. It is characterized by excessive growth and aberrant differentiation of keratinocytes, but is fully reversible with appropriate therapy. The trigger of the keratinocyte response is thought to be activation of the cellular immune system, with T cells, dendritic cells and various immune-related cytokines and chemokines implicated in pathogenesis. The newest therapies for psoriasis target its immune components and may predict potential treatments for other inflammatory human diseases.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17314973     DOI： 10.1038/nature05663

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


  446 in total

1.  miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ.

Authors:  Yueyuan Xiao; Haizhen Wang; Chang Wang; Bijun Zeng; Xueyong Tang; Yujin Zhang; Youhua Peng; Meijunzi Luo; Pan Huang; Zhibo Yang
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

2.  Enhancement of keratinocyte differentiation by rose absolute oil.

Authors:  Jin-Hwa Kim; Dae-Kyoung Choi; Sang-Sin Lee; Sun Ja Choi; Chang Deok Kim; Tae-Jin Yoon; Jeung-Hoon Lee
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

Review 3.  New insights in the immunologic basis of psoriasis.

Authors:  Kristine E Nograles; Batya Davidovici; James G Krueger
Journal:  Semin Cutan Med Surg       Date:  2010-03

4.  Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal.

Authors:  T Simonart; M Heenen; O Lejeune
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

Review 5.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

6.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.

Authors:  Seemal R Desai; Ilona J Frieden; Joel M Gelfand; Whitney High; Arthur Kavanaugh; Ashfaq A Marghoob; David M Ozog; Ted Rosen; Linda Stein Gold; Bruce Strober; Neil Swanson; George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

7.  Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.

Authors:  Ling-Juan Zhang; George L Sen; Nicole L Ward; Andrew Johnston; Kimberly Chun; Yifang Chen; Christopher Adase; James A Sanford; Nina Gao; Melanie Chensee; Emi Sato; Yi Fritz; Jaymie Baliwag; Michael R Williams; Tissa Hata; Richard L Gallo
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

8.  Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.

Authors:  Jean Christopher Chamcheu; Vaqar M Adhami; Stephane Esnault; Mario Sechi; Imtiaz A Siddiqui; Kenneth A Satyshur; Deeba N Syed; Shah-Jahan M Dodwad; Maria-Ines Chaves-Rodriquez; B Jack Longley; Gary S Wood; Hasan Mukhtar
Journal:  Antioxid Redox Signal       Date:  2016-10-04       Impact factor: 8.401

Review 9.  Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.

Authors:  Prativa Biswasroy; Deepak Pradhan; Biswakanth Kar; Goutam Ghosh; Goutam Rath
Journal:  AAPS PharmSciTech       Date:  2021-05-26       Impact factor: 3.246

10.  METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages.

Authors:  Irina Ushach; Amanda M Burkhardt; Cynthia Martinez; Peter A Hevezi; Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Ricardo Valle-Rios; Monica I Vazquez; Bernhard Homey; Albert Zlotnik
Journal:  Clin Immunol       Date:  2014-12-05       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.